The Molecular Events in Early Life That Lead to AMD
Principal Investigator
Przemyslaw Sapieha, PhD
Hôpital Maisonneuve-Rosemont (Canada)
Montreal, Québec, Canada
About the Research Project
Program
Award Type
Innovative Research
Award Amount
$600,000
Active Dates
July 01, 2022 - June 30, 2025
Grant ID
M2022015I
Goals
We aim to identify the molecular mechanisms by which lifestyle habits such as Western-style diets reprogram immune cells in the eye throughout life, making them susceptible to triggering age-related macular degeneration (AMD).
Summary
- We will investigate if a history of obesity triggers a persistent memory state in immune cells and predisposes to heightened inflammation and AMD. We developed a mouse model that allows us to render mice obese and subsequently make them lose weight to study the behavior of immune cells in the eye and AMD.
- We will assess if past obesity induces long-term changes in the genes of immune cells. We will also identify the immune cells that are affected and that exacerbate AMD.
- We will explore if interfering with the genetic changes in immune cells brought upon by obesity can improve AMD.
Unique and Innovative
While there have been significant efforts placed on identifying genetic predispositions to various forms of AMD, there are presently only treatments available for the wet form of the disease. The current research project explores the root causes of AMD and seeks to identify a molecular mechanism that explains why genetics are relatively poor predictors of who will ultimately develop AMD. The studies will explore why environmental factors are important predictors of disease or may compound the effects of genetic predisposition.
Foreseeable Benefits
AMD is a leading cause of blindness in industrialized countries. This study will aim to identify how early life metabolic stressors, such as those collectively linked to obesity, can drive a disease of aging such as AMD, and this long after metabolic equilibrium is reestablished. Ultimately, findings from this research may identify causes, potential therapeutics, or prognostic tools for AMD.
Grants
Related Grants
Macular Degeneration Research
How Age-Related Macular Degeneration Risk Factors Interact in Disease Development
Active Dates
July 01, 2023 - June 30, 2026
Principal Investigator
Freya Mowat, PhD
How Age-Related Macular Degeneration Risk Factors Interact in Disease Development
Active Dates
July 01, 2023 - June 30, 2026
Principal Investigator
Freya Mowat, PhD
Macular Degeneration Research
Exploring the Role of Gut Bacteria in Early AMD
Active Dates
September 01, 2020 - August 31, 2023
Principal Investigator
Christopher Hammond, MD, MRCP, FRCOphth
Exploring the Role of Gut Bacteria in Early AMD
Active Dates
September 01, 2020 - August 31, 2023
Principal Investigator
Christopher Hammond, MD, MRCP, FRCOphth
Macular Degeneration Research
The Gut Bacteria and AMD in Aging Women
Active Dates
September 01, 2020 - August 31, 2023
Principal Investigator
Amy Millen, PhD
The Gut Bacteria and AMD in Aging Women
Active Dates
September 01, 2020 - August 31, 2023
Principal Investigator
Amy Millen, PhD